Can-Fite is currently enrolling patients in a pivotal Phase III clinical study evaluating Namodenoson for the treatment of advanced hepatocellular carcinoma (HCC) in patients with Child-Pugh B7 liver ...
Can-Fite BioPharma Ltd. (NYSEMKT: CANF) is leading the bulls in Monday’s session on positive developments from a phase 2 trial. The company announced development of its drug candidate CF102, which is ...
A look at the weighted underlying holdings of the SPDR— S&P Kensho Future Security ETF (Symbol: FITE) shows an impressive 10.2% of holdings on a weighted basis have experienced insider buying within ...
Phase III study protocol for Namodenoson in the treatment of advanced liver cancer patients is now being prepared and will be presented to FDA in an End of Phase II meeting PETACH TIKVA, ...
Former state representative Charlene Fite is running for Arkansas House District 24 after previously retiring. Fite cites renewed health and a desire to address issues affecting children, seniors, and ...
The gross proceeds to Can-Fite from the exercise of the warrants are expected to be approximately $2.4 million, prior to deducting placement agent fees and estimated offering expenses. H.C. Wainwright ...
LAS VEGAS, NEVADA - SEPTEMBER 24: Hailie Deegan, driver of the #1 Craftsman Ford, waits on the grid prior to the NASCAR Camping World Truck Series Victoria’s Voice Foundation 200 presented by Westgate ...
If you purchase an independently reviewed product or service through a link on our website, Rolling Stone may receive an affiliate commission. There are no shortage of streaming services vying for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback